European Respiratory Society Monograph, Vol. 87. 2020
ISBN (electronic): 978-1-84984-112-2
DOI: 10.1183/2312508X.erm8619
This Monograph provides the clinician with an up-to-date summary of the substantial evidence in our understanding of pleural disease. It covers key aspects relevant to clinicians, including mechanisms, pathophysiology, epidemiology, diagnostics, relevant experimental models and interventions. Although broad in scope, readers will be able to reach into individual chapters to gain a focused summary of specific areas relevant to their clinical or scientific practice.
Preface John R. Hurst Eur Respir Monogr 2020; 87: v | |
Guest Editors
Eur Respir Monogr 2020; 87: vi-vii | |
Introduction Nick A. Maskell, Christian B. Laursen, Y.C. Gary Lee, Najib M. Rahman Eur Respir Monogr 2020; 87: viii-x | |
List of abbreviations
Eur Respir Monogr 2020; 87: xii | |
Epidemiology: why is pleural disease becoming more common? Uffe Bodtger, Robert J. Hallifax Eur Respir Monogr 2020; 87: 1-12 | |
The pathophysiology of breathlessness and other symptoms associated with pleural effusions Rajesh Thomas, Y.C. Gary Lee, Eleanor K. Mishra Eur Respir Monogr 2020; 87: 13-28 | |
In vitro and in vivo laboratory models of pleural disease Xuan Yao, Nikolaos I. Kanellakis Eur Respir Monogr 2020; 87: 29-47 | |
Radiology in pleural disease: what is the role of chest radiographs, CT and PET in modern management? Laura Duerden, Rachel Benamore, Anthony Edey Eur Respir Monogr 2020; 87: 48-72 | |
Thoracic ultrasound: a key tool beyond procedure guidance Radhika A. Banka, Søren H. Skaarup, Rachel M. Mercer, Christian B. Laursen Eur Respir Monogr 2020; 87: 73-89 | |
Pleural interventions: less is more? Maged Hassan, Mohammed Munavvar, John P. Corcoran Eur Respir Monogr 2020; 87: 90-18 | |
Pleural physiology: what do we understand and what should we measure in clinical practice? Michael Gregory Lester, David Feller-Kopman, Fabien Maldonado Eur Respir Monogr 2020; 87: 105-119 | |
Medical thoracoscopy in 2020: essential and future techniques Valentina Pinelli, Amelia O. Clive Eur Respir Monogr 2020; 87: 120-137 | |
Optimal diagnosis and treatment of malignant pleural disease: challenging the guidelines David T. Arnold, Mark Roberts, Momen Wahidi, Rahul Bhatnagar Eur Respir Monogr 2020; 87: 138-154 | |
Pleural infection: moving from treatment to prevention Eihab O. Bedawi, Najib M. Rahman Eur Respir Monogr 2020; 87: 155-171 | |
Effusions related to TB Jane Alexandra Shaw, Liju Ahmed, Coenraad F.N. Koegelenberg Eur Respir Monogr 2020; 87: 172-192 | |
Pneumothorax: how to predict, prevent and cure Robert J. Hallifax, Steven Walker, Stefan J. Marciniak Eur Respir Monogr 2020; 87: 193-210 | |
Nonspecific pleuritis Christopher Kapp, Julius Janssen, Fabien Maldonado, Lonny Yarmus Eur Respir Monogr 2020; 87: 211-217 | |
Nonmalignant pleural effusions: are they as benign as we think? Steven Walker, Samira Shojaee Eur Respir Monogr 2020; 87: 218-231 | |
Mesothelioma: is chemotherapy alone a thing of the past? Anna C. Bibby, Kevin G. Blyth, Daniel H. Sterman, Arnaud Scherpereel Eur Respir Monogr 2020; 87: 232-249 | |
Novel technology in the pleural space: more than just indwelling pleural catheters Rachel M. Mercer, Robert J. Hallifax, Nick A. Maskell Eur Respir Monogr 2020; 87: 250-262 | |
The role of surgery in pleural disease Elizabeth Belcher, John G. Edwards Eur Respir Monogr 2020; 87: 263-281 | |
The specialist pleural service: when, why and who? Vineeth George, Matthew Evison Eur Respir Monogr 2020; 87: 282-294 | |